ABASAGLAR 100 units/ml, solution for injection in a cartridge 5 cartridges of 3 ml
Active ingredients: Insulin glargine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 cartridges of 3 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ABASAGLAR 100 unités/ml, solution injectable en cartouche
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 5 cartouche(s) en verre de 3 ml
- Marketing authorisation holder
- ELI LILLY NEDERLAND (PAY-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66513085CIP73001616CIP133400930016169Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INSULINE GLARGINEsolution | 100 unités · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.